About Sensotrend
Sensotrend is a Healthcare company based in Tampere (Finland) founded in 2013. Automated diabetes diary is offered for blood sugar monitoring. Its focus areas include Life Sciences, Diabetes and In-Vitro Diagnostics.
Company details
Sensotrend was founded in 2013 in Tampere, Finland, within the health technology sector. Software is developed to assist diabetes patients by analyzing blood sugar levels. Data from conventional analyzers is collected and stored in a database for monitoring purposes. The product remains in its pilot and testing phase, with a commercial launch anticipated in late 2017.
- Headquarters Tampere, Finland
- SectorsHealthcare
- Email••••••••
- Website sensotrend.com
- Social LinkedIn X Facebook
- Latest Funding Round$229.75K (USD), Grant
Jan 2021
- InvestorsEuropean Union
& 1 more
Funding Insights of Sensotrend
- Total Rounds 2
- Last Round Grant — $229,753
- Investors Count 2
All 2 funding rounds of Sensotrend with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $229,753 | Grant | – | – | |
| Jun 2014 | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Sensotrend
Sensotrend has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Startup Sauna.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are accelerated via a 7-week program across diverse sectors. | startupsauna.com | Espoo, Finland | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Sensotrend
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Sensotrend
3 dated milestones of Sensotrend across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Sensotrend is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $230K.
Web traffic of Sensotrend
The website of Sensotrend (sensotrend.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▲ 7.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sensotrend
Sensotrend was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Sensotrend is headquartered in Tampere, Finland.
Sensotrend was founded in 2013 in Tampere, Finland, within the health technology sector. Software is developed to assist diabetes patients by analyzing blood sugar levels. Data from conventional analyzers is collected and stored in a database for monitoring purposes. The product remains in its pilot and testing phase, with a commercial launch anticipated in late 2017.
Sensotrend has 2 investors. Key investors include European Union, and Startup Sauna.